Is monkeypox risk of establishment in non-endemic nations real?

Question

Accepted Answer

The Risk of Monkeypox Establishment in Non-Endemic Nations is Real

The World Health Organization (WHO) has confirmed that the risk of monkeypox becoming established in countries where it is not typically found is a genuine concern. As of Wednesday, more than 1,000 confirmed cases have been reported to the WHO from 29 non-endemic countries. While no deaths have been reported from these current outbreaks, the virus has been circulating and causing fatalities in endemic African nations for decades.
Global Spread Beyond Endemic Regions

The current wave of monkeypox cases has spread significantly beyond its traditional geographic boundaries. Over 1,000 confirmed cases have now been identified in 29 countries that are not considered endemic for the disease. This rapid dissemination has led to the recognition of apparent community transmission in some of these nations, with cases now including women, broadening the demographic affected beyond the predominantly male demographic initially observed among men who have sex with men. Greece, for example, reported its first case involving a man with recent travel history to Portugal, illustrating the international connectivity of transmission.
Understanding Monkeypox Symptoms and Vulnerable Populations

Initial symptoms of monkeypox typically include a high fever, swollen lymph nodes, and a rash that resembles chickenpox blisters. The WHO has expressed particular concern regarding the potential threat the virus poses to vulnerable groups, such as pregnant women and children. The sudden emergence of monkeypox outside of endemic areas suggests that undetected transmission may have been occurring for an unspecified period, highlighting the need for heightened vigilance and surveillance.
Public Health Response and Vaccination Strategies

In response to the growing number of cases, public health measures are being implemented. Individuals exhibiting symptoms are advised to isolate at home and seek medical consultation, while household members are encouraged to avoid close contact. In regions where vaccines are accessible, they are being prioritised for individuals at higher risk of exposure, including healthcare workers. Post-exposure vaccination, ideally administered within four days of contact, is being considered for high-risk close contacts, such as sexual partners and household members. The WHO is also actively assessing the availability of vaccine doses and the production capacity of manufacturers to inform future distribution strategies. The smallpox vaccine, belonging to the same orthopoxvirus family, has demonstrated a high degree of efficacy against monkeypox and is being considered as a key tool in containment efforts.

Reading history

Hide →

This history is cleared when the page is closed.

Is monkeypox risk of establishment in non-endemic nations real?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends